Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01178619
Other study ID # MMC10095-2010CTIL
Secondary ID
Status Withdrawn
Phase N/A
First received August 8, 2010
Last updated August 27, 2013
Start date September 2010
Est. completion date August 2012

Study information

Verified date August 2013
Source Meir Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

Intrauterine growth restriction is being suspected in cases where the fetal estimated weight is less then the 10 th percentile for its gestational age. Abdominal circumference is the most influenced measurement in this cases. Head circumference on the other hand can be or not be influenced. Previous studies have shown that transverse cerebellar diameter (TCD) is constant to gestational age and is not influenced by IUGR.Other showed lower TCD in IUGR fetuses. We would like to study the differences in cerebellar, vermian and corpus callosum growth between normal to IUGR fetuses and between symmetrical and asymmetrical IUGR. In this observational study we will include pregnant women between 28-37 gestational week with a singleton otherwise normal pregnancies. We will measure the fetal TCD, vermian distances and the CC, abdominal circumference, head circumference and femur length. we will compeer these measurements according to the following groups:normal fetuses, symmetrical and asymmetrical IUGR.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 28 Weeks to 37 Weeks
Eligibility Inclusion Criteria:

- singleton,

- 28-37 GA,

- well dated pregnancy.

Exclusion Criteria:

- multifetal pregnancies,

- no first trimester dating,

- fetuses with known chromosomal or structural anomalies.

Study Design

Observational Model: Case Control


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Meir Medical Center
See also
  Status Clinical Trial Phase
Completed NCT01729468 - Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Phase 4
Completed NCT01648855 - Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn N/A
Completed NCT00930397 - Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
Recruiting NCT02825277 - Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies N/A